Fecal Occult Blood Screening before Cardiac Surgery
The Thoracic and Cardiovascular Surgeon · 01.01.2024 · 72 (01) · 021-028
DOI: 10.1055/a-2052-8912 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.01.2024. Verfasst von Yoshiyuki Takami und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Fujita Health University School of Medicine, Toyoake, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cardiac Surgical Procedures. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
Concerns of gastrointestinal (GI) bleeding after cardiac surgery are increasing with increased use of antiplatelets and anticoagulants. We investigated the roles of preoperative screening for fecal occult blood by fecal immunochemical test (FIT) widely used to detect GI bleeding and cancer.
Methods
A retrospective review was done in 1,663 consecutive patients undergoing FIT before cardiac surgery between years 2012 and 2020. One or two rounds of FIT were performed 2 to 3 weeks before surgery, when antiplatelets and anticoagulants were not suspended yet.
Results
Positive FIT (> 30 μg of hemoglobin/g of feces) was observed in 227 patients (13.7%). Preoperative risk factors for positive FIT included age > 70 years, anticoagulants, and chronic kidney disease. Of those with positive FIT, 180 patients (79%) received preoperative endoscopy, including gastroscopy (n = 139), colonoscopy (n = 9), and both (n = 32), with no findings of bleeding. The most common finding of gastroscopy was atrophic gastritis (36%) while early gastric cancer was detected in 2 patients. The most common finding of colonoscopy was colon polyps (42%) while colorectal cancer was detected in 5 patients. Of 180 FIT-positive patients receiving endoscopy, 8 (4.4%) underwent preoperative GI treatment, while postoperative GI events were documented in 28 (15.6%). Of 1,436 with negative FIT, 21 (1.5%) presented GI complications after surgery.
Conclusion
Preoperative FIT, which is influenced by anticoagulant use, has little impacts on identification of GI bleeding sites. However, it may be useful to detect GI malignant lesions, potentially impacting operative risks, surgical strategies, and postoperative management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Fujita Health University School of Medicine, Toyoake, Japan.
ORCID-Profile: Yoshiyuki Takami
Zitieren
APA
Takami, Y., Maekawa, A., Yamana, K., Akita, K., Amano, K., Sakurai, Y., & Takagi, Y. (2024). Fecal Occult Blood Screening before Cardiac Surgery. The Thoracic and Cardiovascular Surgeon, 72(01), 021-028. https://doi.org/10.1055/a-2052-8912
Vancouver
Takami Y, Maekawa A, Yamana K, Akita K, Amano K, Sakurai Y, et al. Fecal Occult Blood Screening before Cardiac Surgery. The Thoracic and Cardiovascular Surgeon. 2024;72(01):021-028. doi:10.1055/a-2052-8912
BibTeX
@article{Takami2024,
author = {Takami, Yoshiyuki and Maekawa, Atsuo and Yamana, Koji and Akita, Kiyotoshi and Amano, Kentaro and Sakurai, Yusuke and Takagi, Yasushi},
title = {Fecal Occult Blood Screening before Cardiac Surgery},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2024},
volume = {72},
number = {01},
pages = {021--028},
doi = {10.1055/a-2052-8912}
}
EUVIMED